CHTP Key Stats
- 'Mad Money' Lightning Round: Zynga Can Go Higher The Street 03/08 01:00 ET
- Lightning Round: Zynga, Bob Evans Farms & More Yahoo 03/07 18:37 ET
- Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan The Street 03/07 13:57 ET
- Chelsea Therapeutics Joins NORD in Promoting Awareness for Rare Disease Day GlobeNewswire 02/28 07:00 ET
- Chelsea Therapeutics: Caution Warranted Yahoo 02/25 08:49 ET
- This Week in Biotech: Buyouts, an FDA Approval, and Clinical Data. Oh, My! Yahoo 02/22 12:21 ET
- 3 Humongous Health-Care Stocks This Week Yahoo 02/22 08:25 ET
- Chelsea Therapeutics International Ltd: FDA Approval Just the First Hurdle Yahoo 02/21 18:31 ET
- Biotech Stock Mailbag: Raptor, Chelsea, Oncogenex, More Hate Mail! The Street 02/21 01:00 ET
- Company news for February 20, 2014 - Corporate Summary Zacks 02/20 10:06 ET
CHTP Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Chelsea Therapeutics Intl is up 213.3% over the last year vs S&P 500 Total Return up 24.21%, Actelion up 98.29%, and Prana Biotechnology up 310.0%.
Balance Sheet View Statement
Pro Ratings for CHTP
Pro Strategies Featuring CHTP
Did Chelsea Therapeutics Intl make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Headquarters Country: United States
- Headquarters State/Province: North Carolina
- Incorporation Country: United States
- Incorporation State/Province: Delaware
Chelsea Therapeutics International, Ltd., is a specialty pharmaceutical company focused on acquisition, development and commercialization of pharmaceutical products for the treatment of a variety of human diseases.